NewEdge Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.02M | Sell |
1,938
-102
| -5% | -$53.6K | 0.01% | 1284 |
|
|
2025
Q1 | $1.29M | Sell |
2,040
-760
| -27% | -$482K | 0.01% | 1048 |
|
|
2024
Q4 | $1.99M | Sell |
2,800
-1,630
| -37% | -$1.16M | 0.01% | 829 |
|
|
2024
Q3 | $4.66M | Buy |
4,430
+62
| +1% | +$65.2K | 0.03% | 504 |
|
|
2024
Q2 | $4.59M | Buy |
4,368
+260
| +6% | +$273K | 0.03% | 474 |
|
|
2024
Q1 | $3.95M | Sell |
4,108
-617
| -13% | -$594K | 0.03% | 466 |
|
|
2023
Q4 | $4.33M | Buy |
4,725
+2,179
| +86% | +$2M | 0.04% | 398 |
|
|
2023
Q3 | $2.1M | Sell |
2,546
-1,027
| -29% | -$845K | 0.02% | 586 |
|
|
2023
Q2 | $2.57M | Sell |
3,573
-1,408
| -28% | -$1.01M | 0.03% | 509 |
|
|
2023
Q1 | $4.09M | Buy |
4,981
+962
| +24% | +$790K | 0.05% | 338 |
|
|
2022
Q4 | $2.57M | Buy |
4,019
+1,818
| +83% | +$1.16M | 0.07% | 288 |
|
|
2022
Q3 | $1.52M | Buy |
2,201
+960
| +77% | +$661K | 0.02% | 505 |
|
|
2022
Q2 | $733K | Buy |
+1,241
| New | +$733K | 0.01% | 817 |
|
|
2022
Q1 | – | Sell |
-1,518
| Closed | -$959K | – | 1522 |
|
|
2021
Q4 | $959K | Buy |
1,518
+867
| +133% | +$548K | 0.01% | 754 |
|
|
2021
Q3 | $394K | Buy |
651
+29
| +5% | +$17.6K | 0.01% | 815 |
|
|
2021
Q2 | $347K | Buy |
622
+8
| +1% | +$4.46K | 0.01% | 841 |
|
|
2021
Q1 | $291K | Sell |
614
-106
| -15% | -$50.2K | 0.01% | 825 |
|
|
2020
Q4 | $348K | Sell |
720
-22
| -3% | -$10.6K | 0.01% | 715 |
|
|
2020
Q3 | $415K | Buy |
742
+118
| +19% | +$66K | 0.01% | 627 |
|
|
2020
Q2 | $389K | Sell |
624
-469
| -43% | -$292K | 0.02% | 606 |
|
|
2020
Q1 | $534K | Buy |
1,093
+473
| +76% | +$231K | 0.03% | 438 |
|
|
2019
Q4 | $232K | Buy |
+620
| New | +$232K | 0.01% | 734 |
|
|
2019
Q2 | – | Sell |
-493
| Closed | -$202K | – | 694 |
|
|
2019
Q1 | $202K | Buy |
+493
| New | +$202K | 0.01% | 624 |
|
|
2018
Q4 | – | Sell |
-1,182
| Closed | -$478K | – | 698 |
|
|
2018
Q3 | $478K | Buy |
+1,182
| New | +$478K | 0.04% | 368 |
|
|
2017
Q4 | – | Sell |
-494
| Closed | -$232K | – | 422 |
|
|
2017
Q3 | $232K | Buy |
494
+454
| +1,135% | +$213K | 0.04% | 329 |
|
|
2017
Q2 | $20K | Buy |
+40
| New | +$20K | ﹤0.01% | 742 |
|